Johnson & Johnson (NYSE:JNJ) is a perennial favorite among investors, thanks to its long history and reliable dividend payouts. The company operates a plethora of consumer brands and has been able to withstand the test of time. That being said, it is possible to find stocks that might be more appealing in more ways than one.
Most investors love Johnson & Johnson for its diversified business, and the fact that it's a defensive consumer products company that is able to withstand macroeconomic ebbs and flows. Oh, and the dividend yield of nearly 3% also doesn't hurt. But there's another company that's arguably better in some of these respects: Verizon Communications (NYSE:VZ). One stock that I like more than JNJ at the moment is biotech blue chip Gilead Sciences (NASDAQ:GILD), as its trailing P/E ratio of roughly 7 is far less than what Johnson & Johnson is currently fetching on the markets (around 19). If forced to pick a better stock, I believe Visa (NYSE:V) could give J&J a strong run for its money.
Source: Motley Fool
Related Articles:
- 7 Stocks With A Strong Cash To Dividend Coverage
- Optimizing Your Asset Allocation
- Dividend Growth Stocks Are My Conviction
- 5 Higher Yielding, Lower Risk Stocks To Perk Up Your Dividend Income
- 6 Dividend Growth Stocks With Very Little Debt
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.